{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:18:10Z","timestamp":1787998690561,"version":"build-2784847793"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1245\/s10434-024-15499-z","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T21:03:43Z","timestamp":1716930223000},"page":"5975-5983","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Important Predictive Factors for the Prognosis of Patients With Peritoneal Metastasis of Gastric Cancer"],"prefix":"10.1245","volume":"31","author":[{"given":"Bahar Canbay","family":"Torun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erman","family":"Sobutay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge Eren","family":"Akbulut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezer","family":"Saglam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serpil","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yonemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"Canbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"15499_CR1","doi-asserted-by":"publisher","first-page":"4882","DOI":"10.3390\/jcm10214882.PMID:34768402;PMCID:PMC8584453","volume":"10","author":"A Rijken","year":"2021","unstructured":"Rijken A, Lurvink RJ, Luyer MDP, et al. The burden of peritoneal metastases from gastric cancer: a systematic review on the incidence, risk factors and survival. J Clin Med. 2021;10:4882. https:\/\/doi.org\/10.3390\/jcm10214882.PMID:34768402;PMCID:PMC8584453.","journal-title":"J Clin Med"},{"issue":"Suppl 1","key":"15499_CR2","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.21037\/jgo-20-232.PMID:33968423;PMCID:PMC8100722","volume":"12","author":"I Manzanedo","year":"2021","unstructured":"Manzanedo I, Pereira F, Serrano \u00c1, et al. Review of management and treatment of peritoneal metastases from gastric cancer origin. J Gastrointest Oncol. 2021;12(Suppl 1):S20\u20139. https:\/\/doi.org\/10.21037\/jgo-20-232.PMID:33968423;PMCID:PMC8100722.","journal-title":"J Gastrointest Oncol"},{"key":"15499_CR3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, et al. ESMO guidelines committee. Electronic address: Gastric cancer: ESMO clinical practice guideline for diagnosis, treatment, and follow-up. Ann Oncol. 2022;33:1005\u201320. https:\/\/doi.org\/10.1016\/j.annonc.2022.07.004.","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"15499_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10120-016-0662-9","volume":"20","author":"D Kobayashi","year":"2017","unstructured":"Kobayashi D, Kodera Y. Intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis. Gastric Cancer. 2017;20(Suppl 1):111\u201321. https:\/\/doi.org\/10.1007\/s10120-016-0662-9. (Epub 1 November 2016 PMID: 27803990).","journal-title":"Gastric Cancer"},{"key":"15499_CR5","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/ags3.12060.PMID:29863151;PMCID:PMC5881364","volume":"2","author":"J Kitayama","year":"2018","unstructured":"Kitayama J, Ishigami H, Yamaguchi H, et al. Treatment of patients with peritoneal metastases from gastric cancer. Ann Gastroenterol Surg. 2018;2:116\u201323. https:\/\/doi.org\/10.1002\/ags3.12060.PMID:29863151;PMCID:PMC5881364.","journal-title":"Ann Gastroenterol Surg."},{"key":"15499_CR6","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.ejso.2018.10.119","volume":"45","author":"H Ishigami","year":"2019","unstructured":"Ishigami H, Omori T, Fukushima R, et al. Long-term normothermic intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis: results from clinical trials over a decade in Japan. Eur J Surg Oncol. 2019;45:e6\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2018.10.119.","journal-title":"Eur J Surg Oncol."},{"key":"15499_CR7","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18:1575\u201381. https:\/\/doi.org\/10.1245\/s10434-011-1631-5.","journal-title":"Ann Surg Oncol"},{"key":"15499_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/jso.23633","volume":"110","author":"U Rudloff","year":"2014","unstructured":"Rudloff U, Langan RC, Mullinax JE, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. J Surg Oncol. 2014;110:275\u201384. https:\/\/doi.org\/10.1002\/jso.23633.","journal-title":"J Surg Oncol"},{"key":"15499_CR9","doi-asserted-by":"publisher","first-page":"4647","DOI":"10.1245\/s10434-020-09465-8","volume":"28","author":"WJ Koemans","year":"2019","unstructured":"Koemans WJ, Houwink A, Van der Kaaij RT, et al. Perioperative management of gastric cancer patients treated with (sub)total gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy (HIPEC): lessons learned. Ann Surg Oncol. 2021;28:4647\u201354. https:\/\/doi.org\/10.1245\/s10434-020-09465-8.","journal-title":"Ann Surg Oncol"},{"key":"15499_CR10","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ejso.2020.05.021","volume":"47","author":"M Alyami","year":"2021","unstructured":"Alyami M, Bonnot PE, Mercier F, et al. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancer. Eur J Surg Oncol. 2021;47:123\u20137. https:\/\/doi.org\/10.1016\/j.ejso.2020.05.021.","journal-title":"Eur J Surg Oncol"},{"key":"15499_CR11","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1200\/JCO.2018.77.8613","volume":"36","author":"H Ishigami","year":"2018","unstructured":"Ishigami H, Fujiwara Y, Fukushima R, et al. Phase III trial comparing intraperitoneal and intravenous paclitaxel plus s-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial. J Clin Oncol. 2018;36:1922\u20139. https:\/\/doi.org\/10.1200\/JCO.2018.77.8613.","journal-title":"J Clin Oncol"},{"key":"15499_CR12","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/JCO.18.01688","volume":"37","author":"PE Bonnot","year":"2019","unstructured":"Bonnot PE, Piessen G, Kepenekian V, et al. Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastases (CYTO-CHIP study): a propensity score analysis. J Clin Oncol. 2019;37:2028\u201340.","journal-title":"J Clin Oncol"},{"key":"15499_CR13","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1245\/s10434-020-08739-5","volume":"28","author":"B Badgwell","year":"2021","unstructured":"Badgwell B, Ikoma N, Murphy MB, et al. A phase II trial of cytoreduction, gastrectomy, and hyperthermic intraperitoneal perfusion with chemotherapy for patients with gastric cancer and carcinomatosis or positive cytology. Ann Surg Oncol. 2021;28:258\u201364.","journal-title":"Ann Surg Oncol."},{"key":"15499_CR14","unstructured":"NCCN Guidelines version 1.2023 Gastric Cancer; GAST-C 3 of 3, 7\/29\/2023."},{"key":"15499_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1245\/s10434-016-5487-6","volume":"24","author":"Y Yonemura","year":"2017","unstructured":"Yonemura Y, Ishibashi H, Hirano M, et al. Effects of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy and neoadjuvant intraperitoneal\/systemic chemotherapy on peritoneal metastases from gastric cancer. Ann Surg Oncol. 2017;24:478\u201385. https:\/\/doi.org\/10.1245\/s10434-016-5487-6. (Epub 9 August 2016 PMID: 27506661).","journal-title":"Ann Surg Oncol"},{"issue":"Suppl 1","key":"15499_CR16","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.21037\/jgo-20-121.PMID:33968425;PMCID:PMC8100720","volume":"12","author":"E Canbay","year":"2021","unstructured":"Canbay E, Canbay Torun B, Cosarcan K, et al. Surgery with hyperthermic intraperitoneal chemotherapy after response to induction chemotherapy in patients with peritoneal metastasis of gastric cancer. J Gastrointest Oncol. 2021;12(Suppl 1):S47-56. https:\/\/doi.org\/10.21037\/jgo-20-121.PMID:33968425;PMCID:PMC8100720.","journal-title":"J Gastrointest Oncol"},{"key":"15499_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"},{"issue":"1","key":"15499_CR18","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29\u201342.","journal-title":"Ann Surg"},{"key":"15499_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European organization for research and treatment of cancer, national cancer institute of the United States, national cancer institute of Canada. J Natl Cancer Inst. 2000;92:205\u201316.","journal-title":"J Natl Cancer Inst"},{"key":"15499_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien\u2013Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg."},{"key":"15499_CR21","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) v5.0 in National cancer institute; cancer therapy evaluation program. Retrieved xxxx at https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm."},{"key":"15499_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s0039-6060(96)80145-0","volume":"119","author":"Y Yonemura","year":"1996","unstructured":"Yonemura Y, Fujimura T, Nishimura G, et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery. 1996;119:437\u201344. https:\/\/doi.org\/10.1016\/s0039-6060(96)80145-0. (PMID: 8644010).","journal-title":"Surgery"},{"key":"15499_CR23","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.3390\/jcm12206527.PMID:37892663;PMCID:PMC10607605","volume":"12","author":"AJ Jain","year":"2023","unstructured":"Jain AJ, Badgwell BD. Current evidence for the use of HIPEC and cytoreductive surgery in gastric cancer metastatic to the peritoneum. J Clin Med. 2023;12:6527. https:\/\/doi.org\/10.3390\/jcm12206527.PMID:37892663;PMCID:PMC10607605.","journal-title":"J Clin Med"},{"key":"15499_CR24","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ejso.2006.03.007","volume":"32","author":"Y Yonemura","year":"2006","unstructured":"Yonemura Y, Bandou E, Sawa T, et al. Neoadjuvant treatment of gastric cancer with peritoneal dissemination. Eur J Surg Oncol. 2006;32:661\u20135. https:\/\/doi.org\/10.1016\/j.ejso.2006.03.007. (Epub 18 April 2006 PMID: 16621433).","journal-title":"Eur J Surg Oncol"},{"key":"15499_CR25","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s10147-008-0836-5","volume":"13","author":"S Tamura","year":"2008","unstructured":"Tamura S, Miki H, Okada K, et al. Pilot study of intraperitoneal administration of paclitaxel and oral S-1 for patients with peritoneal metastasis due to advanced gastric cancer. Int J Clin Oncol. 2008;13:536\u201340. https:\/\/doi.org\/10.1007\/s10147-008-0836-5. (Epub 18 December 2008 PMID: 19093182).","journal-title":"Int J Clin Oncol"},{"key":"15499_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jso.21324","volume":"100","author":"Y Yonemura","year":"2009","unstructured":"Yonemura Y, Endou Y, Shinbo M, et al. Safety and efficacy of bidirectional chemotherapy for treatment of patients with peritoneal dissemination from gastric cancer: selection for cytoreductive surgery. J Surg Oncol. 2009;100:311\u20136. https:\/\/doi.org\/10.1002\/jso.21324. (PMID: 19697437).","journal-title":"J Surg Oncol"},{"key":"15499_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4251\/wjgo.v2.i2.85.PMID:21160926;PMCID:PMC2998933","volume":"2","author":"Y Yonemura","year":"2010","unstructured":"Yonemura Y, Elnemr A, Endou Y, et al. Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol. 2010;2:85\u201397. https:\/\/doi.org\/10.4251\/wjgo.v2.i2.85.PMID:21160926;PMCID:PMC2998933.","journal-title":"World J Gastrointest Oncol"},{"key":"15499_CR28","doi-asserted-by":"publisher","first-page":"3726","DOI":"10.1245\/s10434-011-1770-8","volume":"18","author":"Y Fujiwara","year":"2011","unstructured":"Fujiwara Y, Takiguchi S, Nakajima K, et al. Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination. Ann Surg Oncol. 2011;18:3726\u201331. https:\/\/doi.org\/10.1245\/s10434-011-1770-8. (Epub 17 May 2011 PMID: 21584835).","journal-title":"Ann Surg Oncol"},{"key":"15499_CR29","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1007\/s11605-012-2059-3","volume":"16","author":"M Imano","year":"2012","unstructured":"Imano M, Yasuda A, Itoh T, et al. Phase II study of single intraperitoneal chemotherapy followed by systemic chemotherapy for gastric cancer with peritoneal metastasis. J Gastrointest Surg. 2012;16:2190\u20136. https:\/\/doi.org\/10.1007\/s11605-012-2059-3. (Epub 26 October 2012 PMID: 23099736).","journal-title":"J Gastrointest Surg"},{"key":"15499_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00595-013-0603-8","volume":"44","author":"M Imano","year":"2014","unstructured":"Imano M, Okuno K. Treatment strategies for gastric cancer patients with peritoneal metastasis. Surg Today. 2014;44:399\u2013404. https:\/\/doi.org\/10.1007\/s00595-013-0603-8. (Epub 16 May 2013 PMID: 23677598).","journal-title":"Surg Today"},{"key":"15499_CR31","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1245\/s10434-013-3443-2","volume":"21","author":"E Canbay","year":"2014","unstructured":"Canbay E, Mizumoto A, Ichinose M, et al. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan. Ann Surg Oncol. 2014;21:1147\u201352. https:\/\/doi.org\/10.1245\/s10434-013-3443-2. (Epub 20 December 2013 PMID: 24356799).","journal-title":"Ann Surg Oncol"},{"key":"15499_CR32","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.ejso.2006.03.014","volume":"32","author":"A Garofalo","year":"2006","unstructured":"Garofalo A, Valle M, Garcia J, et al. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites. Eur J Surg Oncol. 2006;32:682\u20135. https:\/\/doi.org\/10.1016\/j.ejso.2006.03.014. (Epub 21 April 2006 PMID: 16631341).","journal-title":"Eur J Surg Oncol"},{"key":"15499_CR33","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ejso.2007.05.015","volume":"34","author":"E Facchiano","year":"2008","unstructured":"Facchiano E, Scaringi S, Kianmanesh R, et al. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer. Eur J Surg Oncol. 2008;34:154\u20138. https:\/\/doi.org\/10.1016\/j.ejso.2007.05.015. (Epub 20 July 2007 PMID: 17640844).","journal-title":"Eur J Surg Oncol"},{"key":"15499_CR34","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.3748\/wjg.v16.i15.1901.PMID:20397270;PMCID:PMC2856833","volume":"16","author":"MC Ba","year":"2010","unstructured":"Ba MC, Cui SZ, Lin SQ, et al. Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites. World J Gastroenterol. 2010;16:1901\u20137. https:\/\/doi.org\/10.3748\/wjg.v16.i15.1901.PMID:20397270;PMCID:PMC2856833.","journal-title":"World J Gastroenterol"},{"key":"15499_CR35","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1245\/s10434-022-12761-0","volume":"30","author":"BL Green","year":"2023","unstructured":"Green BL, Blumenthaler AN, Gamble LA, McDonald JD, Robinson K, Connolly M, et al. Cytoreduction and HIPEC for gastric carcinomatosis: multi-institutional analysis of two phase II clinical trials. Ann Surg Oncol. 2023;30:1852\u201360. https:\/\/doi.org\/10.1245\/s10434-022-12761-0.","journal-title":"Ann Surg Oncol"},{"key":"15499_CR36","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00280-002-0439-1","volume":"49","author":"P Marchettini","year":"2002","unstructured":"Marchettini P, Stuart OA, Mohamed F, et al. Docetaxel: pharmacokinetics and tissue levels after intraperitoneal and intravenous administration in a rat model. Cancer Chemother Pharmacol. 2002;49:499\u2013503. https:\/\/doi.org\/10.1007\/s00280-002-0439-1. (Epub 26 April 2002 PMID: 12107555).","journal-title":"Cancer Chemother Pharmacol"},{"issue":"16 Pt 1","key":"15499_CR37","first-page":"5896","volume":"9","author":"RJ Morgan Jr","year":"2003","unstructured":"Morgan RJ Jr, Doroshow JH, Synold T, et al. Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics. Clin Cancer Res. 2003;9(16 Pt 1):5896\u2013901 (PMID: 14676112).","journal-title":"Clin Cancer Res"},{"key":"15499_CR38","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1245\/s10434-013-3055-x","volume":"21","author":"T Yoshikawa","year":"2014","unstructured":"Yoshikawa T, Tanabe K, Nishikawa K. Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trial. Ann Surg Oncol. 2014;21:213\u20139. https:\/\/doi.org\/10.1245\/s10434-013-3055-x.","journal-title":"Ann Surg Oncol"},{"key":"15499_CR39","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1093\/bjs\/znab200","volume":"108","author":"PE Bonnot","year":"2021","unstructured":"Bonnot PE, Lintis A, Mercier F, et al. FREGAT and BIG-RENAPE networks. Prognosis of poorly cohesive gastric cancer after complete cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (CYTO-CHIP study). Br J Surg. 2021;108:1225\u201335. https:\/\/doi.org\/10.1093\/bjs\/znab200.","journal-title":"Br J Surg"},{"key":"15499_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1200\/JCO.22.02867","volume":"42","author":"B Rau","year":"2024","unstructured":"Rau B, Lang H, Koenigsrainer A, et al. Effect of hyperthermic intraperitoneal chemotherapy on cytoreductive surgery in gastric cancer with synchronous peritoneal metastases: the phase III GASTRIPEC-I trial. J Clin Oncol. 2024;42:146\u201356. https:\/\/doi.org\/10.1200\/JCO.22.02867.","journal-title":"J Clin Oncol"},{"key":"15499_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-023-00994-5","author":"AY Li","year":"2024","unstructured":"Li AY, Sedighim S, Tajik F, et al. Regional therapy approaches for gastric cancer with limited peritoneal disease. J Gastrointest Cancer. 2024. https:\/\/doi.org\/10.1007\/s12029-023-00994-5.","journal-title":"J Gastrointest Cancer"},{"key":"15499_CR42","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.7150\/jca.30074","volume":"10","author":"DD Xiong","year":"2019","unstructured":"Xiong DD, Zeng CM, Jiang L, Luo DZ, Chen G. Ki-67\/MKI67 as a predictive biomarker for clinical outcome in gastric cancer patients: an updated meta-analysis and systematic review involving 53 studies and 7078 patients. J Cancer. 2019;10:5339\u201354.","journal-title":"J Cancer"},{"key":"15499_CR43","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s00280-014-2410-3","volume":"73","author":"A Wu","year":"2014","unstructured":"Wu A, Jia Y, Dong B, et al. Apoptosis and KI 67 index correlate with preoperative chemotherapy efficacy and better predict the survival of gastric cancer patients with combined therapy. Cancer Chemother Pharmacol. 2014;73:885\u201393.","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15499-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-15499-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-15499-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T18:19:04Z","timestamp":1722881944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-15499-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["15499"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-15499-z","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"19 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}